Results of three logistic regression models to analyze independent factors for type 1 diabetes after pregnancy in women with GDM
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Model 1 | ||
| Age ≤30 years* | 5.033 (1.224–20.689) | 0.025 |
| Insulin for GDM† | 10.836 (2.069–56.752) | 0.005 |
| No. of positive antibodies‡ | ||
| 1 | 5.646 (1.120–28.453) | 0.036 |
| 2 | 7.013 (1.001–49.115) | 0.050 |
| 3 | 66.427 (9.209–479.177) | <0.0005 |
| Model 2 | ||
| Age ≤30 years* | 3.854 (0.982–15.128) | 0.053 |
| Insulin for GDM† | 20.955 (3.069–143.093) | 0.002 |
| ICA positivity‡ | 10.320 (1.916–55.582) | 0.007 |
| GADA positivity‡ | 7.631 (1.245–46.788) | 0.028 |
| IA-2A positivity‡ | 0.462 (0.047–4.572) | 0.509 |
| Model 3 | ||
| Age ≤30 years* | 3.932 (1.008–15.336) | 0.049 |
| Insulin for GDM† | 16.331 (2.977–89.573) | 0.001 |
| ICA positivity‡ | 9.460 (2.154–41.545) | 0.003 |
| GADA positivity‡ | 4.745 (1.066–21.119) | 0.041 |
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Model 1 | ||
| Age ≤30 years* | 5.033 (1.224–20.689) | 0.025 |
| Insulin for GDM† | 10.836 (2.069–56.752) | 0.005 |
| No. of positive antibodies‡ | ||
| 1 | 5.646 (1.120–28.453) | 0.036 |
| 2 | 7.013 (1.001–49.115) | 0.050 |
| 3 | 66.427 (9.209–479.177) | <0.0005 |
| Model 2 | ||
| Age ≤30 years* | 3.854 (0.982–15.128) | 0.053 |
| Insulin for GDM† | 20.955 (3.069–143.093) | 0.002 |
| ICA positivity‡ | 10.320 (1.916–55.582) | 0.007 |
| GADA positivity‡ | 7.631 (1.245–46.788) | 0.028 |
| IA-2A positivity‡ | 0.462 (0.047–4.572) | 0.509 |
| Model 3 | ||
| Age ≤30 years* | 3.932 (1.008–15.336) | 0.049 |
| Insulin for GDM† | 16.331 (2.977–89.573) | 0.001 |
| ICA positivity‡ | 9.460 (2.154–41.545) | 0.003 |
| GADA positivity‡ | 4.745 (1.066–21.119) | 0.041 |
Age at the time of blood sample during pregnancy; OR against women >30 years.
OR against women without insulin for GDM.
OR against women negative for antibodies.